| Reduced miR-99a-3p levels in systemic lupus erythematosus may promote B cell proliferation via NCAPG and the PI3K/AKT signaling pathway. | Reduced miR-99a-3p levels in systemic lupus erythematosus may promote B cell proliferation via NCAPG and the PI3K/AKT signaling pathway.
Zhu QH, Zhou YL, Yang M, Yang BB, Cao WT, Yuan LM, Deng DQ. | 03/21/2024 |
| The Diagnostic and Therapeutic Value of NCAPG as a Proposed Biomarker Candidate in Acute Liver Failure. | The Diagnostic and Therapeutic Value of NCAPG as a Proposed Biomarker Candidate in Acute Liver Failure.
Zhang L, Ma T, Yan Y, Chen YY, Zhu XH, Ren HZ. | 11/22/2023 |
| Galectin-1-mediated high NCAPG expression correlates with poor prognosis in gastric cancer. | Galectin-1-mediated high NCAPG expression correlates with poor prognosis in gastric cancer.
Zheng T, Qian T, Zhou H, Cheng Z, Liu G, Huang C, Dou R, Liu F, You X., Free PMC Article | 07/10/2023 |
| NCAPG as a novel prognostic biomarker in numerous cancers: a meta-analysis and bioinformatics analysis. | NCAPG as a novel prognostic biomarker in numerous cancers: a meta-analysis and bioinformatics analysis.
Lin J, Li G, Bai Y, Xie Y., Free PMC Article | 04/26/2023 |
| The U2AF65/circNCAPG/RREB1 feedback loop promotes malignant phenotypes of glioma stem cells through activating the TGF-beta pathway. | The U2AF65/circNCAPG/RREB1 feedback loop promotes malignant phenotypes of glioma stem cells through activating the TGF-β pathway.
Li H, Jiang Y, Hu J, Xu J, Chen L, Zhang G, Zhao J, Zong S, Guo Z, Li X, Zhao X, Jing Z., Free PMC Article | 01/21/2023 |
| The role of NCAPG in various of tumors. | The role of NCAPG in various of tumors.
Cai X, Gao J, Shi C, Guo WZ, Guo D, Zhang S. | 10/29/2022 |
| NCAPG Promotes Pulmonary Artery Smooth Muscle Cell Proliferation as a Promising Therapeutic Target of Idiopathic Pulmonary Hypertension: Bioinformatics Analysis and Experiment Verification. | NCAPG Promotes Pulmonary Artery Smooth Muscle Cell Proliferation as a Promising Therapeutic Target of Idiopathic Pulmonary Hypertension: Bioinformatics Analysis and Experiment Verification.
Fu B, Li Y, Shi X, Liu P, Zhang Y, Tian H., Free PMC Article | 10/22/2022 |
| Overexpression of NCAPG in ovarian cancer is associated with ovarian cancer proliferation and apoptosis via p38 MAPK signaling pathway. | Overexpression of NCAPG in ovarian cancer is associated with ovarian cancer proliferation and apoptosis via p38 MAPK signaling pathway.
Yu H, Zou D, Ni N, Zhang S, Zhang Q, Yang L., Free PMC Article | 08/27/2022 |
| NCAPG promotes tumorigenesis of bladder cancer through NF-kappaB signaling pathway. | NCAPG promotes tumorigenesis of bladder cancer through NF-κB signaling pathway.
Tang F, Yu H, Wang X, Shi J, Chen Z, Wang H, Wan Z, Fu Q, Hu X, Zuhaer Y, Liu T, Yang Z, Peng J. | 08/20/2022 |
| NCAPG Promotes the Proliferation of Renal Clear Cell Carcinoma via Mediating with CDK1. | NCAPG Promotes the Proliferation of Renal Clear Cell Carcinoma via Mediating with CDK1.
Li H, Zheng P, Li Z, Han Q, Zhou B, Wang X, Wang K., Free PMC Article | 05/28/2022 |
| Increased expression of NCAPG (Non-SMC condensing I complex subunit G) is associated with progression and poor prognosis of lung adenocarcinoma. | Increased expression of NCAPG (Non-SMC condensing I complex subunit G) is associated with progression and poor prognosis of lung adenocarcinoma.
Wang X, Tian X, Sui X, Li X, Zhao X, Han K, Sun L, Dong Y., Free PMC Article | 04/16/2022 |
| NCAPG is a prognostic biomarker of immune infiltration in non-small-cell lung cancer. | NCAPG is a prognostic biomarker of immune infiltration in non-small-cell lung cancer.
Zhou Y, Fan Y, Mao Y, Lou M, Liu X, Yuan K, Tong J. | 04/16/2022 |
| NCAPG promotes the oncogenesis and progression of non-small cell lung cancer cells through upregulating LGALS1 expression. | NCAPG promotes the oncogenesis and progression of non-small cell lung cancer cells through upregulating LGALS1 expression.
Sun H, Zhang H, Yan Y, Li Y, Che G, Zhou C, Nicot C, Ma H., Free PMC Article | 04/9/2022 |
| NCAPG is a prognostic biomarker associated with vascular invasion in hepatocellular carcinoma. | NCAPG is a prognostic biomarker associated with vascular invasion in hepatocellular carcinoma.
Guo ZY, Zhu ZT. | 03/26/2022 |
| NCAPG, mediated by miR-378a-3p, regulates cell proliferation, cell cycle progression, and apoptosis of oral squamous cell carcinoma through the GSK-3beta/beta-catenin signaling. | NCAPG, mediated by miR-378a-3p, regulates cell proliferation, cell cycle progression, and apoptosis of oral squamous cell carcinoma through the GSK-3β/β-catenin signaling.
Li J, Sun S, Li J, Zhao X, Li Z, Sha T, Cui Z. | 12/18/2021 |
| Inhibition of NCAPG expression inactivates the Wnt/beta-catenin signal to suppresses endometrial cancer cell growth in vitro. | Inhibition of NCAPG expression inactivates the Wnt/β-catenin signal to suppresses endometrial cancer cell growth in vitro.
Liu C, Yan Y, Di F, Li W, Yin X, Dong L. | 11/22/2021 |
| Propofol Represses Cell Growth and Metastasis by Modulating the Circular RNA Non-SMC Condensin I Complex Subunit G/MicroRNA-200a-3p/RAB5A Axis in Glioma. | Propofol Represses Cell Growth and Metastasis by Modulating the Circular RNA Non-SMC Condensin I Complex Subunit G/MicroRNA-200a-3p/RAB5A Axis in Glioma.
Zhang L, Chen H, Tian C, Zheng D. | 11/13/2021 |
| NCAPG confers trastuzumab resistance via activating SRC/STAT3 signaling pathway in HER2-positive breast cancer. | NCAPG confers trastuzumab resistance via activating SRC/STAT3 signaling pathway in HER2-positive breast cancer.
Jiang L, Ren L, Chen H, Pan J, Zhang Z, Kuang X, Chen X, Bao W, Lin C, Zhou Z, Huang D, Yang J, Huang H, Wang L, Hou N, Song L., Free PMC Article | 03/27/2021 |
| Overexpression of NCAPG inhibits cardia adenocarcinoma apoptosis and promotes epithelial-mesenchymal transition through the Wnt/beta-catenin signaling pathway. | Overexpression of NCAPG inhibits cardia adenocarcinoma apoptosis and promotes epithelial-mesenchymal transition through the Wnt/β-catenin signaling pathway.
Zhang X, Zhu M, Wang H, Song Z, Zhan D, Cao W, Han Y, Jia J. | 11/21/2020 |
| Novel key genes in triple-negative breast cancer identified by weighted gene co-expression network analysis. | Novel key genes in triple-negative breast cancer identified by weighted gene co-expression network analysis.
Chen J, Qian X, He Y, Han X, Pan Y. | 09/19/2020 |
| NCAPG as an essential oncogene for hepatocellular carcinoma tumor growth. | Genome-wide CRISPR knockout screens identify NCAPG as an essential oncogene for hepatocellular carcinoma tumor growth.
Wang Y, Gao B, Tan PY, Handoko YA, Sekar K, Deivasigamani A, Seshachalam VP, OuYang HY, Shi M, Xie C, Goh BKP, Ooi LL, Man Hui K., Free PMC Article | 05/23/2020 |
| NCAPG was regulated by miR-99a-3p, and its overexpression was involved in castration-resistant prostate cancer pathogenesis. | Regulation of NCAPG by miR-99a-3p (passenger strand) inhibits cancer cell aggressiveness and is involved in CRPC.
Arai T, Okato A, Yamada Y, Sugawara S, Kurozumi A, Kojima S, Yamazaki K, Naya Y, Ichikawa T, Seki N., Free PMC Article | 10/19/2019 |
| NCAPG might play an oncogenic role in the development of liver cancer. | Silencing non-SMC chromosome-associated polypeptide G inhibits proliferation and induces apoptosis in hepatocellular carcinoma cells.
Liu K, Li Y, Yu B, Wang F, Mi T, Zhao Y. | 03/16/2019 |
| this study demonstrates that NCAPG plays an important role in the development and progression of hepatocellular carcinoma (HCC), and that it may be a novel therapeutic target for patients with HCC. | Overexpression of non‑SMC condensin I complex subunit G serves as a promising prognostic marker and therapeutic target for hepatocellular carcinoma.
Liu W, Liang B, Liu H, Huang Y, Yin X, Zhou F, Yu X, Feng Q, Li E, Zou Z, Wu L., Free PMC Article | 04/21/2018 |
| Data indicate that three genes, KIF14, NCAPG and CENPE that were upregulated in Pediatric high-grade gliomas (pHGGs) and were direct miR-137 or miR-6500-3p targets. | Downregulation of miR-137 and miR-6500-3p promotes cell proliferation in pediatric high-grade gliomas.
Liang ML, Hsieh TH, Ng KH, Tsai YN, Tsai CF, Chao ME, Liu DJ, Chu SS, Chen W, Liu YR, Liu RS, Lin SC, Ho DM, Wong TT, Yang MH, Wang HW., Free PMC Article | 12/2/2017 |